 |
|
|
| |
Post-Treatment Viral Evolution Assessment Using Ultra-Deep Pyrosequencing in Samples from Patients with Hepatitis C Virus Infection: The EXTEND Study
|
| |
| |
Reported by Jules Levin
AASLD 2013 Nov 1-5 Wash DC
Inge Dierynck1, Kim Thys1, Doug J. Bartels2, Anne Ghys1, Elizabeth Van Rossem1, Eileen Z. Zhang2, Andrew Davis2, Mark Friedman2, Tara L. Kieffer2, Jeroen Aerssens1, Sandra De Meyer1, and Jim C. Sullivan2
1Janssen Infectious Diseases BVBA, Beerse, Belgium; 2. Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA
|
| |
|
|
|
|
|
